Inyx, Inc. (IYXI)

Market Cap	53.00 -99.9%
Revenue (ttm)	85.04M +201.2%
Net Income	-37.13M
EPS	-0.79
Shares Out	53.11M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,425
Average Volume	46,482
Open	0.0000
Previous Close	0.0000
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0000
Beta	-131.88
RSI	40.96
Earnings Date	n/a

About Inyx, Inc.

Inyx, Inc., through its wholly-owned subsidiaries, operates as a specialty pharmaceutical company in the United States, Canada, and Europe. It develops and manufactures prescription and over-the-counter pharmaceutical products. The company manufactures hydrocarbon aerosols, a delivery system for dermatological and topical drug applications; metered dose inhalers that are used for respiratory conditions; dry powdered inhalers used for respiratory ailments; metered dose nasal and throat pumps, and sprays; and sterile salines and injectables. It f...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Employees: 572
• Stock Exchange: OTCMKTS
• Ticker Symbol: IYXI

Financial Performance

In 2005, Inyx, Inc.'s revenue was $49.57 million, an increase of 215.72% compared to the previous year's $15.70 million. Losses were -$31.01 million, 83.0% more than in 2004.